Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020.


Journal

Archivos de bronconeumologia
ISSN: 1579-2129
Titre abrégé: Arch Bronconeumol
Pays: Spain
ID NLM: 0354720

Informations de publication

Date de publication:
May 2023
Historique:
received: 16 01 2023
revised: 18 02 2023
accepted: 21 02 2023
medline: 5 5 2023
pubmed: 27 3 2023
entrez: 26 3 2023
Statut: ppublish

Résumé

Exposure to environmental tobacco smoke (ETS) is associated with increased mortality and morbidity. The objective of this study was to estimate the impact of ETS exposure in Spain on mortality in 2020 in the population aged 35 years and over. A method of estimating attributable mortality (AM) based on the prevalence of ETS exposure was applied. Prevalence data were obtained from a representative study conducted in Spain and the relative risks were derived from a meta-analysis. AM point estimates are presented along with 95% confidence intervals (95% CI), calculated using a bootstrap naive procedure. AM, both overall and by smoking habit, was estimated for each combination of sex, age group, and cause of death (lung cancer and ischemic heart disease). A sensitivity analysis was performed. A total of 747 (95% CI 676-825) deaths were attributable to ETS exposure, of which 279 (95% CI 256-306) were caused by lung cancer, and 468 (95% CI 417-523) by ischemic heart disease. Three-quarters (75.1%) of AM occurred in men and 60.9% in non-smokers. When chronic obstructive pulmonary disease and cerebrovascular disease are included, the burden of AM is estimated at 2242 deaths. ETS exposure is associated with 1.5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. These data underline the need for health authorities to focus on reducing exposure to ETS in all settings and environments.

Identifiants

pubmed: 36967344
pii: S0300-2896(23)00096-0
doi: 10.1016/j.arbres.2023.02.017
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Meta-Analysis Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

305-310

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Mónica Pérez-Ríos (M)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, IDIS, Santiago de Compostela, Spain.

Diana Carolina López-Medina (DC)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Facultad de Medicina, Universidad Cooperativa de Colombia, Colombia; Fundación Carolina, Colombia.

Carla Guerra-Tort (C)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Julia Rey-Brandariz (J)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain.

Leonor Varela-Lema (L)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain. Electronic address: leonor.varela@usc.es.

María Isolina Santiago-Pérez (MI)

Servicio de Epidemiología, Dirección General de Salud Pública, Xunta de Galicia, Spain.

Cristina Candal (C)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain.

Agustin Montes (A)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, IDIS, Santiago de Compostela, Spain.

María José López (MJ)

Servicio de Evaluación y Métodos de Intervención, Agència de Salut Pública de Barcelona, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain.

Regina Dalmau (R)

Hospital Universitario La Paz, Madrid, Spain.

Maraino Provencio (M)

Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

Esteve Fernández (E)

Unidad de Control del Tabaco, Programa de Prevención y Control del Cáncer, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat (Barcelona), Spain; Ciber de Enfermedades Respiratorias, CIBERes, Madrid, Spain.

Ana Blanco (A)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Alberto Ruano-Ravina (A)

Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Ciber de Epidemidemiología y Salud Pública, CIBEResp, Madrid, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, IDIS, Santiago de Compostela, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH